Skip to Content
A new committee has been named to lead a national search for the Barlow Family Director of the Vanderbilt Brain Institute, announced Provost and Vice Chancellor for Academic Affairs Susan R. Wente and Jeff Balser, president and CEO of Vanderbilt University Medical Center and dean of the Vanderbilt University School of Medicine.
“The Vanderbilt Brain Institute sets Vanderbilt apart as a leader in interdisciplinary research and teaching,” Wente said. “In research, education and training, its programs have long fostered excellence. The institute brings together faculty and students from across the university in a common mission of collaboration and discovery, exemplifying the core beliefs of our Academic Strategic Plan. Our goal is to identify a superior candidate who can build upon—and extend—the institute’s track record of success and innovation.”
The endowed director position was established in 2016 through a generous commitment made by David S. Barlow, a leader in the global pharmaceutical industry who serves on Vanderbilt’s Technology Transfer Advisory Committee.
“Neuroscience continues to be one of the most rapidly advancing areas of scientific discovery, yet estimates indicate that treating brain disorders and diseases costs the U.S. economy more than $1.5 trillion each year. With its internationally recognized trans-institutional programs in research, training and clinical services, the VBI is poised to play an increasingly important role as we seek new treatments and cures for neurodegenerative diseases, psychiatric disorders and other brain conditions,” Balser said. “I want to express my appreciation to the search committee for this important work to identify a new leader who will advance the institute’s missions.”
The new search committee will be co-chaired by René Marois, professor and chair of psychology and professor of radiology and radiological sciences, and Danny Winder, professor of molecular physiology and biophysics, professor of psychiatry and behavioral sciences, professor of pharmacology, director of the Vanderbilt Center for Addiction Research and associate director of the Vanderbilt Medical Scientist Training Program.
“I am grateful to René and Danny for their leadership in this important search,” Wente said. “They both have deep knowledge of the institute and the needs of our brain and neuroscience research enterprise, and I look forward to working with them.”
Ronald B. Emeson continues as interim director of VBI, a role he assumed in July 2016. Emeson, previously the institute’s associate director, is the Joel G. Hardman Professor of Pharmacology, professor of biochemistry, professor of molecular physiology and biophysics, and professor of psychiatry and behavioral sciences.
The committee members are:
For more information, click here.
Jan Read, (615) 322-NEWS
Health and Medicine, myVU, myVU News, releases, Research, Strategic Plan, Trans-institutional Programs Academic Strategic Plan, Jeff Balser, Office of the Provost, Susan R. Wente, vanderbilt brain institute
There are lots of ways to keep up with Vanderbilt research news. Choose your preferred method:
Sign up for the weekly Research News @Vanderbilt e-newsletter.